Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy

Name: Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
Creator: Maria Asdourian
Published: 2022-12-16T08:08:16.521Z
Keywords: Dermatology, Cancer Immunotherapy, Drug Adverse Reactions, Survival Analysis, Medical Oncology

Asdourian, Maria; Jacoby, Ted; Shah, Nishi; Otto, Tracey; Thompson, Leah; Dee, Edward Christopher; Reynolds, Kerry; Semenov, Yevgeniy; Chen, Steven

doi:10.17632/mrdyhdh78k.1

Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy

Published: 16 December 2022| Version 1 | DOI: 10.17632/mrdyhdh78k.1

Contributors:

Maria Asdourian, Ted Jacoby, Nishi Shah, Tracey Otto, Leah Thompson, Edward Christopher Dee, Kerry Reynolds, Yevgeniy Semenov, Steven Chen

Description

This file includes additional details on study methodology and supplemental figures (Kaplan-Meier curves).

Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy

Description

Files

Categories

Licence